Company profile
IMAI Medtech
IMAI Medtech develops a 3D-histology platform for cancer diagnostics. The Zurich company combines automated tissue processing, imaging and reconstruction t...
Facts
- Segment
- LAB_AUTOMATION
- Country
- Switzerland
- Headquarters
- Zurich
- Founded
- 2024
- Website
- https://www.imai-medtech.com/
About IMAI Medtech
IMAI Medtech develops automated three-dimensional histology for cancer diagnostics and biomedical research. Its platform processes intact tissue, applies staining, captures volumetric images and reconstructs digital models so pathology teams can examine tumour margins and spatial structures beyond the limited view provided by individual thin sections.
Automation standardises preparation and imaging across samples, while analysis software supports navigation through the reconstructed tissue volume. The Zurich company is developing instruments, consumables and computational workflows for laboratories and clinical pathology. Adoption depends on validation and regulatory requirements for each diagnostic use, with current work centred on translating the platform into routine laboratory processes.
Market context
DEVELOPMENT
Summary
Type: Lab automation company
Core: 3D histology platform
Function: Tissue diagnostics
Audience: Pathology laboratories